Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


2012 UCL Awards for Enterprise

Publication date: Jan 20, 2012 02:48 PM

Start: May 17, 2012 06:15 PM

Awards Stage

UCL Enterprise will be once again recognising the efforts and accomplishments of UCL’s innovative and entrepreneurial academics and students. UCL invites you to the 5th annual UCL Awards for Enterprise 2012.

On Thursday 17th May 2012, UCL will honour a new generation of enterprise at the UCL Bloomsbury Theatre, London. The awards ceremony and reception will highlight UCL as a leading hub of innovation and commercial activity, while bringing together academics with businesses and investors.